Literature DB >> 20135058

Low-molecular-weight heparin from Cu2+ and Fe2+ Fenton type depolymerisation processes.

Elena Vismara1, Monica Pierini, Giuseppe Mascellani, Lino Liverani, Marcelo Lima, Marco Guerrini, Giangiacomo Torri.   

Abstract

Hydrogen peroxide (H2O2) and Cu(OAc)2 or FeSO4 (Fenton type reagents) perform heparin (Hep) depolymerisation to low-molecular-weight heparin (LMWH) following a radical chain mechanism. Hydroxyl (OH) radicals which are initially generated from H2O2 reduction by transition metal ions abstract hydrogen atoms on the heparin chain providing carbon centred radicals whose decay leads to the depolymerisation process. The main depolymerisation mechanism involves Hep radical intermediates that cleave the glycosidic linkage at unsulphated uronic acids followed by a 6-O-nonsulphated glucosamine, thus largely preserving the pentasaccharide sequence responsible for the binding to antithrombin III (AT). Both the transition metal ions influence the overall efficiency of the radical chain processes: Fe2+ acting as a catalyst, while Cu2+ acts as a reagent. LMWHs, especially those afforded by Cu2+, are somewhat unstable to the usual basic workup. However, this lack of stability can be eliminated by a previous NaBH4 reduction. Furthermore, with Cu2+, the process is much more reproducible than with Fe2+. Therefore, for the process of Fenton type depolymerisation of heparin, the use of Cu(OAc)2 is clearly preferable to the more "classical" FeSO4. The resulting activities and characteristics of these LMWHs are peculiar to these oxidative radical processes. In addition, LMWH provided by H2O2/Cu(OAc)2 in optimised conditions was found to posses anti-Xa and anti-IIa activities comparable to those of LMWHs currently in clinical use.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20135058     DOI: 10.1160/TH09-02-0084

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Photochemical Preparation of a Novel Low Molecular Weight Heparin.

Authors:  Kyohei Higashi; Saori Hosoyama; Asami Ohno; Sayaka Masuko; Bo Yang; Eric Sterner; Zhenyu Wang; Robert J Linhardt; Toshihiko Toida
Journal:  Carbohydr Polym       Date:  2012-02-01       Impact factor: 9.381

2.  Preparation of low molecular weight heparin using an ultrasound-assisted Fenton-system.

Authors:  Zijian Zhi; Junhui Li; Jianle Chen; Shan Li; Huan Cheng; Donghong Liu; Xingqian Ye; Robert J Linhardt; Shiguo Chen
Journal:  Ultrason Sonochem       Date:  2018-11-20       Impact factor: 7.491

3.  A Fucan Sulfate with Pentasaccharide Repeating Units from the Sea Cucumber Holothuriafloridana and Its Anticoagulant Activity.

Authors:  Zimo Ning; Pin Wang; Zhichuang Zuo; Xuelin Tao; Li Gao; Chen Xu; Zhiyue Wang; Bin Wu; Na Gao; Jinhua Zhao
Journal:  Mar Drugs       Date:  2022-06-03       Impact factor: 6.085

4.  Method to detect contaminants in heparin using radical depolymerization and liquid chromatography-mass spectrometry.

Authors:  Guoyun Li; Chao Cai; Lingyun Li; Li Fu; Yuqing Chang; Fuming Zhang; Toshihiko Toida; Changhu Xue; Robert J Linhardt
Journal:  Anal Chem       Date:  2013-12-23       Impact factor: 6.986

5.  Antioxidant Activity and Biocompatibility of Fructo-Polysaccharides Extracted from a Wild Species of Ornithogalum from Lebanon.

Authors:  Mohammad Kazem Medlej; Cherri Batoul; Hamza Olleik; Suming Li; Akram Hijazi; Ghassan Nasser; Marc Maresca; Céline Pochat-Bohatier
Journal:  Antioxidants (Basel)       Date:  2021-01-07

6.  Characterization of Danaparoid Complex Extractive Drug by an Orthogonal Analytical Approach.

Authors:  Cristina Gardini; Elena Urso; Marco Guerrini; René van Herpen; Pauline de Wit; Annamaria Naggi
Journal:  Molecules       Date:  2017-07-05       Impact factor: 4.411

Review 7.  Developments in Mass Spectrometry for Glycosaminoglycan Analysis: A Review.

Authors:  Lauren E Pepi; Patience Sanderson; Morgan Stickney; I Jonathan Amster
Journal:  Mol Cell Proteomics       Date:  2021-01-06       Impact factor: 5.911

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.